GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.5665
+0.0264 (4.89%)
At close: Oct 24, 2025, 4:00 PM EDT
0.5625
-0.0040 (-0.71%)
After-hours: Oct 24, 2025, 7:47 PM EDT
GeoVax Labs Revenue
GeoVax Labs had revenue of $852.28K in the quarter ending June 30, 2025, with 183.45% growth. This brings the company's revenue in the last twelve months to $6.14M, up 1,943.07% year-over-year. In the year 2024, GeoVax Labs had annual revenue of $3.95M.
Revenue (ttm)
$6.14M
Revenue Growth
+1,943.07%
P/S Ratio
1.00
Revenue / Employee
$361,356
Employees
17
Market Cap
16.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.95M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 81.53K | -303.98K | -78.85% |
| Dec 31, 2021 | 385.50K | -1.44M | -78.86% |
| Dec 31, 2020 | 1.82M | 647.76K | 55.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
GOVX News
- 3 months ago - GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 11 months ago - GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - GlobeNewsWire
- 11 months ago - GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewsWire
- 1 year ago - GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 1 year ago - GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 - GlobeNewsWire